OPTOCIRCUI

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 47149.67 lacs for year ending on 31-MAR-2010 against Rs. 40123.14 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 14687.82 lacs for the year ending on 31-MAR-2010 against Rs. 14025.27 lacs for the year ending on 31-MAR-2009.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 107758.26 lacs for year ending on 31-MAR-2010 against Rs. 81851.97 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 26007.36 lacs for the year ending on 31-MAR-2010 against Rs. 20944.39 lacs for the year ending on 31-MAR-2009.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 33446.44 lacs for quarter ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 6614.42 lacs for the quarter ending on 31-MAR-2010.

Opto Circuits (India) Limited has informed the Exchange that the Company is establishing a subsidiary company in a tax free region in Malaysia.

Opto Circuits (India) Limited has informed the Exchange that "The Company will submit the Audited Financial Results for the financial year ended March 31, 2010 within 60 days from the end of the financial year and will submit the same on or before May 30, 2010. In view of the above, the Company shall not be submitting the un-audited financial results for the quarter ended March 31, 2010".

Opto Circuits (India) Limited has informed the Exchange vide its letter dated April 09, 2010 that "The Board of Directors of the company at their meeting held on this day allotted 15,00,000 Convertible Share Warrants to Mr. Gautam G Gumnani which was kept pending for Foreign Investment Promotion Board's (FIPB) approval. The Company has now received FIPB approval vide Letter No.31(2010)/166(2009) dated 6th April 2010, issued by the Government of India, Ministry of Finance, Department of Economic Affairs, FIPB".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated April 05, 2010, titled "Opto Circuits forays into manufacturing of cardiac stents Acquires Kolkata - based N. S. Remedies Ltd". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OPTO_pr_05042010.ZIP target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange vide its letter dated March 30, 2010 that "Based on the application filed by the company, the Government of India through FIPB has approved the issue and allotment of 15,00,000 convertible share warrants amounting to Rs. 31.50 Crores. However in the official website of FIPB the amount of inflow is mentioned as Rs. 376.27 crores. The company has communicated to FIPB to make necessary amendments."

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 23, 2010, titled "DIOR(TM) from Opto Circuits' European subsidiary becomes the first drug eluting balloon to be used in Canada". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OPTO_pr_23022010.ZIP target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange vide notes to Accounts in the unaudited financial results for the quarter ended December 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on January 28, 2010) regarding the utilisation of QIP issue & share warrants proceeds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OPTOCIRCUI_Utilzn_12022010.zip target=NEW> For more details clic

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 11689.41 lacs for quarter ending on 31-DEC-2009 against Rs. 12086.76 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 3563.22 lacs for the quarter ending on 31-DEC-2009 against Rs. 3889.96 lacs for the quarter ending on 30-SEP-2009.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 25702.5 lacs for quarter ending on 31-DEC-2009 against Rs. 25573.42 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 6568.1 lacs for the quarter ending on 31-DEC-2009 against Rs. 6692.74 lacs for the quarter ending on 30-SEP-2009.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 05, 2010, titled "Opto Circuits' subsidiary receives CE approval for TAXCOR plus". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_pr_05012010.ZIP target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 09 2009, titled "Opto Circuits India set to introduce next generation medical products into world markets."A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_PR_11122009.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 19, 2009, titled "Opto Circuits' US subsidiary launches next-gen patient monitor at German show - MEDICA 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_pr_20112009.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 12, 2009, titled "Opto Circuits ranked amongst Forbes' Asia's 200 Best Under a Billion Companies for second consecutive year". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_PR_12112009.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange vide notes to Accounts in the unaudited financial results for the quarter ended September 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on October 29, 2009) regarding the utilisation of QIP issue & share warrants proceeds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OPTOCIRCUI_ipo_30102009.zip target=NEW> For more details click

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 25573.42 lacs for quarter ending on 30-SEP-2009 against Rs. 23035.9 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 6692.74 lacs for the quarter ending on 30-SEP-2009 against Rs. 5926.65 lacs for the quarter ending on 30-JUN-2009.

Opto Circuits (India) Limited has informed the Exchange that the following items were approved by the Shareholders of the Company at their Annual General Meeting held on September 29, 2009: 1) Adoption of Audited Financial Results for the year ended March 31, 2009 along with the Reports of the Directors and Auditors thereon. 2) Payment of dividend @ Rs. 4.00 per Equity Share of Rs. 10/- each. 3) Re-appointment of Dr. Anvay Mulay as Independent Director. 4) Re-appointment of Mr. Rajkumar Raisinghani as Independent Director. 5) Re-appointment of Mr. Jayesh C Patel as Director. 6) Appointment of

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 29, 2009, titled "Opto subsidiary in US signs OEM agreement with another US company for anesthetic gas monitoring technology". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Optocirc_PR_30092009.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that Company's wholly - owned US-based subsidiary, Criticare Systems Inc. (CSI), has forged a strategic multi-year OEM (Original Equipment Manufacturing) contract with another US company to privately label its anesthesia monitor for the signed partner. The agreement leverages CSI's unique anesthesia gas monitoring technology in applications that involve the calibration and maintenance of anesthesia equipment in some of the leading hospitals in the United States. CSI is an international medical device company that develops, manufactures an

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 23, 2009, titled "Opto subsidiary in US signs agreement with European company for patient monitoring products". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_pr_23092009.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that the Company on September 15, 2009 allotted 2,14,30,484 Equity Shares under Qualified Institutional Placement (QIP) at Rs. 186.65 (Rs. 10/- face value and Rs. 176.65 Premium) and the Company has also obtained the listing approval for these shares.

Opto Circuits (India) Limited has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the Members of the company to be held on September 29, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OptoCir_AGMnot_18092009.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that the duly authorised QIP Committee of the Board of Directors of the Company has at its meeting held on September 10, 2009, approved the Placement Document / Other Documents and finalized the Issue Price. A copy of the QIP Committee Resolution passed by way of Circulation for the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Optocircuit_QIP_10092009.zip target=NEW> For more details clic

Opto Circuits (India) Limited has informed the Exchange that the duly authorised QIP Committee of the Board of Directors of the Company has its meeting held on September 08, 2009, decided to close the Bid Period in relation to the Issue. Further, the Floor Price for the issue of Equity Shares is Rs.186.63 per Equity Share calculated in accordance with Regulation 85 of SEBI ICDR Regulations and the Relevant Date for this purpose is September 04, 2009. Further a copy of the QIP Committee resolution passed by way of circulation shall be available on the NSE website (http://www.nseindia.com) under

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and Share Transfer Books will be closed from September 23, 2009 to September 29, 2009 (both days inclusive) for the purpose of payment of dividend. The Annual General Meeting of the Members of the Company will be held on September 29, 2009.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated August 11, 2009, titled "Opto Circuits develops small and lightweight pulse oximetry monitoring product - M50 NanoSAT (TM) for homecare and physician use". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_PR_11082009.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange vide its letter dated July 29, 2009 that "The Board of Directors of the Company at their meeting held this day inter-alia proceed with the allotment of convertible Share Warrants on preferential basis at Rs.210/- per Share Warrant as approved by the shareholders by Postal Ballot. 25% of the price of Share Warrants has been received". The details of the allotments shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/con

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors of the Company at its's meeting held on July 14, 2007 allotted 11,00,000 convertible Share Warrants, which could be converted into Equity Shares of the Company with a period of 18 months from the date of allotment. Out of the above only 5,40,000 Share Warrant were converted into Equity Shares by one holder and the remaining 5,60,000 Share Warrants lapsed as their holders did not exercised the option of conversion.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 23035.9 lacs for quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 5926.65 lacs for the quarter ending on 30-JUN-2009.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 9811.5 lacs for quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 2848.74 lacs for the quarter ending on 30-JUN-2009.

Opto Circuits (India) Limited has informed the Exchange that the Company had sought the shareholders approval for passing of the Resolutions proposed in the Postal Ballot Notice dated June 11, 2009. The shareholders of the Company have passed special Resolutions by the requisite majority through Postal Ballot Notice dated June 11, 2009 in terms of Section 192A of the Companies Act, 1956, as per the reports of the Scrutinizer and of the Chairman. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet S

Opto Circuits (India) Limited has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001 to transact the following Special Business by the Members of the Company by passing Resolutions through Postal Ballot: (1) Special Resolution under Section 81 1(A) of the Companies Act, 1956, giving Consent to the Board of Directors to issue Equity Shares, ADRs, GDRs, FCCBs or any other Securities as detailed under item No.1 of the Postal Ballot Notice dated June 11, 2009. (2) Special Resolution under Secti

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors at their meeting held on June 18, 2009 have recommended a Dividend of Rs. 4.00 per Equity Share (face value of Rs. 10/- each) for the year 2008-2009, subject to the approval of the Shareholders in the General Meeting.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 11991.66 lacs for quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 4023.89 lacs for the quarter ending on 31-MAR-2009.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 40123.14 lacs for year ending on 31-MAR-2009 against Rs. 32869.35 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 14025.27 lacs for the year ending on 31-MAR-2009 against Rs. 11879.41 lacs for the year ending on 31-MAR-2008.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 21311.6 lacs for quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 5537.44 lacs for the quarter ending on 31-MAR-2009.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 81851.97 lacs for year ending on 31-MAR-2009 against Rs. 46807.84 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 20944.39 lacs for the year ending on 31-MAR-2009 against Rs. 13239.09 lacs for the year ending on 31-MAR-2008.

Opto Circuits (India) Limited has informed the Exchange that "the board of directors of the company at its meeting held on June 03,2009 has approved the following subject to satisfactory receipt of all statutory, regulatory, corporate and other approvals including shareholders at their Meeting, as may be required.(1) Issue, offer and allot equity shares and any other securities which are convertible into or exchangeable with the equity shares of the company for an aggregate amount upto 4.00 Billion Rupees. (Rupee Four Hundred Crores only) or equivalent thereof in one or more Foreign Currency u

Opto Circuits (India) Limited has informed the Exchange that: "The company has received US FDA approval on a next-generation pulse oximeter (SpO2) module, Sequel (TM) developed by its Waukesha-based subsidiary- Criticare Systems Inc. (CSI). The approval enables immediate integration of the module into CSI monitors and marketing and sale of the product to OEM manufacturers across the globe.Sequel (TM) is a miniaturised, motion-tolerant and a more sensitive SpO2 module that is designed to power new generation vital signs monitors and other patient monitors for the entire CSI range of products. T

Opto Circuits (India) Limited has informed the Exchange that: "California-based Mediaid Inc., the subsidiary Company and the International Marketing arm of the Company has received Brazilian FDA agency- Agencia Nacional de Vigilancia Sanitaria (ANVISA)- approval for marketing and sale of the Mediaid brand of US FDA-approved Pulse Oximetry (SPO2) products (Patient Monitors & Sensors) in the Country and surrounding geographies".

Opto Circuits (India) Limited has informed the Exchange that "We intend to announce the audited results of the Company for the financial year ended March 31, 2009 on or before June 30, 2009. In view of this, we request you to exempt us from announcing the Un-audited results as required under Clause 41 of the listing Agreement executed between the Company and your Stock Exchange."

Opto Circuits (India) Limited has informed the Exchange that pursuant to the Provisions of Regulations 8A of the SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 1997, the Company have received declaration from the Promoters, none of their shares are pledged.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 9461.22 lacs for quarter ending on 31-DEC-2008 against Rs. 10435.8 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 3117.79 lacs for the quarter ending on 31-DEC-2008 against Rs. 3858.51 lacs for the quarter ending on 30-SEP-2008.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 21102.14 lacs for quarter ending on 31-DEC-2008 against Rs. 21701.51 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 5262.78 lacs for the quarter ending on 31-DEC-2008 against Rs. 5672.93 lacs for the quarter ending on 30-SEP-2008.

Opto Circuits (India) Limited has informed the Exchange that Maxcor Lifesience, Inc., the newly incorporated subsidiary of the Company (OCI), entered into a strategic cooperation agreement with Micell Technologies, Inc., based in Raleigh, North Carolina, U.S.A. Maxcor and Micell will co-operate in developing and commercializing leading edge Rapamycin (Sirolimus) - based Drug Eluting Stents (DES) and Drug Eluting Balloons (DEB) which will complement OCI's present range of successful paclitaxel-based drug-device combination products. Offering products with both compounds will enable OCI to maxim

Opto Circuits (India) Limited has informed the Exchange vide its letter dated January 12, 2009 that "5,40,000 convertible share warrants were allotted to Mr. Vinod Ramnani Promoter Director in 2007 at Rs. 360/- per warrant. The company has converted these warrants in to 5,40,000 equity shares and allotted the same to Mr. Vinod Ramnani on this day".

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 18670.26 lacs for half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 6883.58 lacs for the half year ending on 30-SEP-2008.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 10435.8 lacs for quarter ending on 30-SEP-2008 against Rs. 8234.47 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 3858.31 lacs for the quarter ending on 30-SEP-2008 against Rs. 3025.3 lacs for the quarter ending on 30-JUN-2008.